Abstract
Low serum vitamin D level has an increased association with risk of multiple sclerosis (MS).There has been no published data on the levels of this vitamin in Indian population with MS. Hence we decided to undertake this study to document if there is evidence of vitamin D deficiency in patients with MS in our population. 26 patients with diagnosis of MS by modified Mc Donald’s criteria were enrolled in this study. Serum vitamin D (1,25 hydroxy) levels were measured by electro-chemiluminescence in our biochemistry lab. An age-matched control group of 202 patients who did not have a diagnosis of MS were included. In our study group 76.9 % had vitamin D level less than 20 ng/ml compared to 65.5 % of control group (p value of 0.019). Our study revealed a trend towards low vitamin D values in Indian MS patients.
Similar content being viewed by others
References
Kurtzke JF. Geography in multiple sclerosis. J Neurol. 1977;215:1–26.
Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67:373–8.
Ladizesky M, Lu Z, Oliveri B, San RN, Diaz S, Holick MF, Ladizesky M, Lu Z, Oliveri B, San RN, Diaz S, Holick MF, et al. Solar ultraviolet B radiation an photo production of vitamin D3 in central and southern areas of Argentina. J Bone Miner Res. 1995;10:545–9.
Cosman F, Nieves J, Herbert J, Shen V, Lindsay R. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res. 1994;9:1097–105.
Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994;44:1687–92.
Auer DP, Schumann EM, Kumpfel T, Gossl C, Trenkwalder C. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesion in multiple sclerosis. Ann Neurol. 2000;47:276–7.
Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuation of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000;48:271–2.
Simpson S Jr, Taylor B, Blizzard L. Higher 25-hydroxyl vitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010;68(2):193–203.
Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010;67(5):618–24.
Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132(5):1146–60.
Smolders J. Vitamin D as an immunomodulator in Multiple sclerosis. J Neuroimmunol. 2008;194:7–17.
Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatr Scand. 1960;35(suppl 147):132–47.
Sutherland JM, Tyrer JH, Eadie MJ. The prevalence of multiple sclerosis in Australia. Brain. 1962;85:146–64.
Leibowitz U, Sharon D, Alter M. Geographical considerations in multiple sclerosis. Brain. 1967;90:871–86.
Kurtzke JF. On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand. 1967;43:257–82.
Geiger R. The climate near the ground. Cambridge: Harvard University Press; 1965. p. 442–6.
Presthus J. Report on the multiple sclerosis investigations in West Norway. Acta Psychiatr Neurol Scand. 1960;35(Suppl 147):88–92.
Westlund K. Distribution and mortality time trend of multiple sclerosis and some other diseases of Norway. Acta Neurol Scand. 1970;46:455–83.
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-Hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–8.
Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008;14(9):1220–4.
Van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007;254(5):581–90.
Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler. 2005;11(3):266–71.
Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatr. 2008;79(2):152–7.
Auer DP, Schumann EM, Kümpfel T, Gössl C, Trenkwalder C. Seasonal fluctuations of gadolinium-enhancin magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000;47(2):276–7.
Smolders J, Mariëlle T, Evelyn P, Paul M, Jan WCT, Jan D, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE. 2009;4(8):e6635.
Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, et al. 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler. 2009;15(11):1280–5.
Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch H-M, Thibault L, et al. A Phase I/II dose-escalation trial of oral vitamin D3 with calcium supplementation in patients with multiple sclerosis. Mult Scler. 2008;14(Suppl 1):S34.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suresh Kumar, R., Syed, S., Anand Kumar, A. et al. Serum Vitamin D Levels in Indian Patients with Multiple Sclerosis. Ind J Clin Biochem 28, 255–258 (2013). https://doi.org/10.1007/s12291-012-0264-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0264-1